DZDaniel Zamanillo
Daniel Zamanillo
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Daniel Zamanillo has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alba Vidal-Torres
Instituto Tecnológico Vale
2 shared publications Begoña Fernández-Pastor
WeLab Barcelona, Parc Científic de Barcelona, Barcelona 08028, Spain
2 shared publications- José Miguel Vela
Autonomous University of Barcelona
2 shared publications - Luz Romero
Drug Discovery and Preclinical Development, ESTEVE, Barcelona, Spain
2 shared publications - Manuel Merlos
Drug Development and Clinical Research, Palau Pharma, Barcelona, Spain
2 shared publications Anna Cabot
WeLab Barcelona, Parc Científic de Barcelona, Barcelona 08028, Spain
1 shared publication
Latest Publications
- Open Access
- 25 September 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (1) , 82-99
Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
- 25 September 2022
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (1) , 82-99
Open AccessBispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
- 1 July 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 711 (1-3) , 63-72
Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects
- 1 July 2013
- Published by Elsevier in European Journal of Pharmacology
- Vol. 711 (1-3) , 63-72
Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects